Investigating long-term risks and STI rates in PrEP users in France
Long-term Evolution of Risky Sexual Behaviors and Prevalence of Sexually Transmitted Infections Among Pre-Exposure Prophylaxis Users: A Retrospective Observational Study in Gironde, France
This study looks at the long-term effects of PrEP on sexual behavior and STI rates in people using it in France to see how it compares between those on PrEP for over a year and those on it for less than a year.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 8 sites (Bordeaux and 7 other locations) |
| Trial ID | NCT06600087 on ClinicalTrials.gov |
What this trial studies
The SAFER-PrEP study examines the long-term effects of Pre-Exposure Prophylaxis (PrEP) on sexual behaviors and the prevalence of sexually transmitted infections (STIs) among users in Aquitaine, France. It compares STI rates between individuals who have been on PrEP for over a year and those who have been on it for less than a year. This observational study collects data through self-administered questionnaires during routine PrEP consultations, aiming to provide insights that could inform future PrEP prescriptions and enhance public health strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are French-speaking individuals over 18 years old who have been using PrEP for at least 6 months.
Not a fit: Patients who are known to be HIV positive will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding of the long-term implications of PrEP use, ultimately enhancing HIV prevention strategies and sexual health outcomes.
How similar studies have performed: Other studies have explored the effects of PrEP on sexual health, but this specific investigation into long-term risks and STI prevalence is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged over 18 years old; * Participants using PrEP for at least 6 months ; * French-speaking, without comprehension disorders ; * being affiliated to health insurance ; * Willing to participate and to sign informed consent. Exclusion Criteria: * Individuals with known HIV positivity;
Where this trial is running
Bordeaux and 7 other locations
- Cegidd de Bordeaux — Bordeaux, France (Recruiting)
- CHU de Bordeaux - Service de médecine interne et maladies infectieuses — Bordeaux, France (Recruiting)
- Maison de la Santé de l'Hôpital Saint-André - Médecine Générale — Bordeaux, France (Recruiting)
- Cabinet de Medecine Generale — Fargues-Saint-Hilaire, France (Not_yet_recruiting)
- Cabinet de Medecine Generale — Le Teich, France (Not_yet_recruiting)
- Cegidd de Libourne — Libourne, France (Not_yet_recruiting)
- Cabinet de Medecine Generale — Mérignac, France (Not_yet_recruiting)
- Cegidd de Perigueux — Périgueux, France (Not_yet_recruiting)
Study contacts
- Principal investigator: Jean-Philippe JOSEPH, Prof — jean-philippe.joseph@u-bordeaux.fr
- Study coordinator: Jean-Philippe JOSEPH, Prof
- Email: jean-philippe.joseph@u-bordeaux.fr
- Phone: (0)5.56.39.05.90
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.